Cargando…

Genomic NGFB variation and multiple sclerosis in a case control study

BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akkad, Denis A, Kruse, Niels, Arning, Larissa, Gold, Ralf, Epplen, Jörg T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613874/ https://www.ncbi.nlm.nih.gov/pubmed/19063739 http://dx.doi.org/10.1186/1471-2350-9-107

Ejemplares similares

Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity
por: Akkad, Denis A., et al.
Publicado: (2015)

On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors
por: Wagenleiter, Sonja EN, et al.
Publicado: (2005)

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2011)

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)
por: Arning, Larissa, et al.
Publicado: (2005)

Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease
por: Arning, Larissa, et al.
Publicado: (2004)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Cholecystokinin A Receptor (CCKAR) Gene Variation Is Associated with Language Lateralization
por: Ocklenburg, Sebastian, et al.
Publicado: (2013)

Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment
por: Levran, Orna, et al.
Publicado: (2011)

Homozygosity mapping and sequencing identify two genes that might contribute to pointing behavior in hunting dogs
por: Akkad, Denis A, et al.
Publicado: (2015)

Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes
por: Aydin, Gülsah, et al.
Publicado: (2018)

Autosomal dominant hereditary spastic paraplegia: Novel mutations in the REEP1 gene (SPG31)
por: Schlang, Katharina J, et al.
Publicado: (2008)

Failure to confirm influence of Methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease
por: Hansen, Wiebke, et al.
Publicado: (2005)

NMDA receptor gene variations as modifiers in Huntington disease: a replication study
por: Saft, Carsten, et al.
Publicado: (2011)

A large deletion in RPGR causes XLPRA in Weimaraner dogs
por: Kropatsch, Regina, et al.
Publicado: (2016)

Endocannabinergic modulation of central serotonergic activity in healthy human volunteers
por: Emons, Barbara, et al.
Publicado: (2023)

Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020)

mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis
por: Yu, Xinhua, et al.
Publicado: (2008)

PCSK6 VNTR Polymorphism Is Associated with Degree of Handedness but Not Direction of Handedness
por: Arning, Larissa, et al.
Publicado: (2013)

Handedness and the X chromosome: The role of androgen receptor CAG-repeat length
por: Arning, Larissa, et al.
Publicado: (2015)

Progressive multiple sclerosis: latest therapeutic developments and future directions
por: Faissner, Simon, et al.
Publicado: (2019)

Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
por: Faissner, Simon, et al.
Publicado: (2022)

PTPRC (CD45) is not associated with multiple sclerosis in a large cohort of German patients
por: Miterski, Bianca, et al.
Publicado: (2002)

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
por: Wiendl, Heinz, et al.
Publicado: (2021)

Variation in genes encoding eosinophil granule proteins in atopic dermatitis patients from Germany
por: Parwez, Qumar, et al.
Publicado: (2008)

An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factors
por: Gödde, René, et al.
Publicado: (2005)

Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
por: Ellrichmann, Gisa, et al.
Publicado: (2011)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

SOX9 Duplication Linked to Intersex in Deer
por: Kropatsch, Regina, et al.
Publicado: (2013)

Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis
por: Schwake, Carolin, et al.
Publicado: (2020)

Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
por: Lee, De-Hyung, et al.
Publicado: (2012)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
por: Thiel, Sandra, et al.
Publicado: (2021)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient
por: Kogel, Ann-Kathrin, et al.
Publicado: (2021)

Genetic variation in dopamine availability modulates the self-reported level of action control in a sex-dependent manner
por: Schlüter, Caroline, et al.
Publicado: (2019)

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study
por: Stasiolek, Mariusz, et al.
Publicado: (2015)

Association of variation in the LAMA3 gene, encoding the alpha-chain of laminin 5, with atopic dermatitis in a German case–control cohort
por: Stemmler, Susanne, et al.
Publicado: (2014)

Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis
por: Duscha, Alexander, et al.
Publicado: (2022)

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study
por: Karamyan, Anush, et al.
Publicado: (2016)

Microstructural White Matter Alterations in Cognitively Impaired Patients at Early Stages of Multiple Sclerosis
por: Schneider, Ruth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgi89fm4g67ohuol5ebn7i8vd3